nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Tapentadol—Angioedema—Prednisolone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Tapentadol—Breast disorder—Methotrexate—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Tapentadol—Vertigo—Prednisolone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Tapentadol—Syncope—Prednisolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Tapentadol—Eye disorder—Betamethasone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Tapentadol—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Tapentadol—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Tapentadol—Angiopathy—Betamethasone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Tapentadol—Convulsion—Prednisolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Tapentadol—Bradycardia—Prednisone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Tapentadol—Angioedema—Triamcinolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Tapentadol—Angioedema—Methylprednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Tapentadol—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Tapentadol—Hallucination—Prednisone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Tapentadol—Vertigo—Triamcinolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Tapentadol—Syncope—Triamcinolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Tapentadol—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Tapentadol—Syncope—Methylprednisolone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Tapentadol—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Tapentadol—Oedema—Prednisolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Tapentadol—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Tapentadol—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Tapentadol—Shock—Prednisolone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Tapentadol—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Tapentadol—Cough—Triamcinolone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Tapentadol—Convulsion—Triamcinolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Tapentadol—Tachycardia—Prednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Tapentadol—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Tapentadol—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Tapentadol—Eye disorder—Prednisone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Tapentadol—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Tapentadol—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Tapentadol—Infestation—Methotrexate—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Tapentadol—Depression—Methotrexate—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Tapentadol—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Tapentadol—Angioedema—Dexamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Tapentadol—Angioedema—Betamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Tapentadol—Angiopathy—Prednisone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Tapentadol—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Tapentadol—Immune system disorder—Prednisone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Tapentadol—Oedema—Triamcinolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Tapentadol—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Tapentadol—Vertigo—Dexamethasone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Tapentadol—Vertigo—Betamethasone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Tapentadol—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Tapentadol—Syncope—Dexamethasone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Tapentadol—Syncope—Betamethasone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Tapentadol—Infection—Triamcinolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Tapentadol—Infection—Methylprednisolone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Tapentadol—Shock—Triamcinolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Tapentadol—Insomnia—Prednisolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Tapentadol—Shock—Methylprednisolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Tapentadol—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Tapentadol—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Tapentadol—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Tapentadol—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Tapentadol—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Tapentadol—Mental disorder—Prednisone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Tapentadol—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Tapentadol—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Tapentadol—Malnutrition—Prednisone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Tapentadol—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Tapentadol—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Tapentadol—Convulsion—Betamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Tapentadol—Convulsion—Dexamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Tapentadol—Anxiety—Betamethasone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Tapentadol—Anxiety—Dexamethasone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Tapentadol—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Tapentadol—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Tapentadol—Vision blurred—Prednisone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Tapentadol—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Tapentadol—Oedema—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Tapentadol—Oedema—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Tapentadol—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Tapentadol—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Tapentadol—Insomnia—Triamcinolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Tapentadol—Insomnia—Methylprednisolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Tapentadol—Infection—Betamethasone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Tapentadol—Infection—Dexamethasone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Tapentadol—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Tapentadol—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Tapentadol—Visual impairment—Methotrexate—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Tapentadol—Shock—Dexamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Tapentadol—Shock—Betamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Tapentadol—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Tapentadol—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Tapentadol—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Tapentadol—Agitation—Prednisone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Tapentadol—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Tapentadol—Tachycardia—Betamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Tapentadol—Angioedema—Prednisone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Tapentadol—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Tapentadol—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Tapentadol—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Tapentadol—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Tapentadol—Vertigo—Prednisone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Tapentadol—Eye disorder—Methotrexate—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Tapentadol—Syncope—Prednisone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Tapentadol—Urticaria—Prednisolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Tapentadol—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Tapentadol—Fatigue—Triamcinolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Tapentadol—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Tapentadol—Hypotension—Betamethasone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Tapentadol—Hypotension—Dexamethasone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Tapentadol—Angiopathy—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Tapentadol—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Tapentadol—Convulsion—Prednisone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Tapentadol—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Tapentadol—Chills—Methotrexate—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Tapentadol—Arthralgia—Prednisone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Tapentadol—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Tapentadol—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Tapentadol—Anxiety—Prednisone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Tapentadol—Insomnia—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Tapentadol—Insomnia—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Tapentadol—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Tapentadol—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Tapentadol—Mental disorder—Methotrexate—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Tapentadol—Malnutrition—Methotrexate—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Tapentadol—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Tapentadol—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Tapentadol—Urticaria—Triamcinolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Tapentadol—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Tapentadol—Oedema—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Tapentadol—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Tapentadol—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Tapentadol—Infection—Prednisone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Tapentadol—Fatigue—Dexamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Tapentadol—Fatigue—Betamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Tapentadol—Shock—Prednisone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Tapentadol—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Tapentadol—Tachycardia—Prednisone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Tapentadol—Skin disorder—Prednisone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Tapentadol—Vision blurred—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Tapentadol—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Tapentadol—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Tapentadol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Tapentadol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Tapentadol—Vertigo—Methotrexate—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Tapentadol—Urticaria—Betamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Tapentadol—Urticaria—Dexamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Tapentadol—Dizziness—Prednisolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Tapentadol—Asthenia—Triamcinolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Tapentadol—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Tapentadol—Insomnia—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Tapentadol—Paraesthesia—Prednisone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Tapentadol—Pruritus—Triamcinolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Tapentadol—Cough—Methotrexate—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Tapentadol—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Tapentadol—Convulsion—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Tapentadol—Dyspepsia—Prednisone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Tapentadol—Arthralgia—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Tapentadol—Decreased appetite—Prednisone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Tapentadol—Rash—Prednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Tapentadol—Dermatitis—Prednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Tapentadol—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Tapentadol—Fatigue—Prednisone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Tapentadol—Headache—Prednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Tapentadol—Constipation—Prednisone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Tapentadol—Confusional state—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Tapentadol—Dizziness—Triamcinolone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Tapentadol—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Tapentadol—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Tapentadol—Infection—Methotrexate—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Tapentadol—Asthenia—Dexamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Tapentadol—Asthenia—Betamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Tapentadol—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Tapentadol—Nausea—Prednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Tapentadol—Pruritus—Betamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Tapentadol—Pruritus—Dexamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Tapentadol—Skin disorder—Methotrexate—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Tapentadol—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Tapentadol—Vomiting—Triamcinolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Tapentadol—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Tapentadol—Rash—Triamcinolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Tapentadol—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Tapentadol—Rash—Methylprednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Tapentadol—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Tapentadol—Urticaria—Prednisone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Tapentadol—Headache—Triamcinolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Tapentadol—Headache—Methylprednisolone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Tapentadol—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Tapentadol—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Tapentadol—Hypotension—Methotrexate—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Tapentadol—Dizziness—Betamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Tapentadol—Dizziness—Dexamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Tapentadol—Insomnia—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Tapentadol—Nausea—Triamcinolone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Tapentadol—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Tapentadol—Nausea—Methylprednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Tapentadol—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Tapentadol—Somnolence—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Tapentadol—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Tapentadol—Vomiting—Dexamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Tapentadol—Vomiting—Betamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Tapentadol—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Tapentadol—Rash—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Tapentadol—Rash—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Tapentadol—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Tapentadol—Dermatitis—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Tapentadol—Fatigue—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Tapentadol—Headache—Betamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Tapentadol—Headache—Dexamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Tapentadol—Asthenia—Prednisone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Tapentadol—Pruritus—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Tapentadol—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Tapentadol—Diarrhoea—Prednisone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Tapentadol—Nausea—Dexamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Tapentadol—Nausea—Betamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Tapentadol—Urticaria—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Tapentadol—Dizziness—Prednisone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Tapentadol—Vomiting—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Tapentadol—Rash—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Tapentadol—Dermatitis—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Tapentadol—Headache—Prednisone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Tapentadol—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Tapentadol—Asthenia—Methotrexate—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Tapentadol—Nausea—Prednisone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Tapentadol—Pruritus—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Tapentadol—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Tapentadol—Dizziness—Methotrexate—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Tapentadol—Vomiting—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Tapentadol—Rash—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Tapentadol—Dermatitis—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Tapentadol—Headache—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Tapentadol—Nausea—Methotrexate—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
